ArticleEuropean radiology2026
Multimodal deep learning for laryngeal squamous cell carcinoma staging using CT and laryngoscopy.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesTo develop and validate a multimodal deep learning model integrating clinical data, contrast-enhanced CT, and laryngoscopic images for differentiating early-stage (I-II) from advanced-stage (III-IV) laryngeal squamous cell carcinoma (LSCC). MATERIALS AND
methodsThis retrospective multicenter study included 450 patients with pathologically confirmed LSCC from two Chinese medical centers. All patients had contrast-enhanced CT, white-light laryngoscopy, and clinical records. They were divided into training (n = 235), internal validation (n = 101), and external validation (n = 114) cohorts. Three single-modality models (CT-based deep learning [CT-DL], laryngoscopy-based multiple instance learning [L-MIL], and a clinical logistic regression model [CL]) and their combinations were compared. A feature-level fusion strategy was applied, and the final integrated multimodal model (CL + CT + L) was built using a stochastic gradient descent (SGD) classifier. Performance was evaluated by AUC, accuracy, sensitivity, specificity, calibration, and decision curve analysis (DCA), with prognostic value assessed by Kaplan-Meier and concordance index (C-index).
resultsA total of 450 patients were included (median age, 62 years [range, 31-88]; 365 men). The integrated multimodal model achieved AUCs of 0.902 (0.833-0.954) in the internal cohort and 0.888 (0.826-0.944) in the external cohort, outperforming all single- and dual-modality models (p < 0.05). Calibration and DCA confirmed strong consistency and clinical utility. The model categorized patients into distinct risk groups, which exhibited notable differences in progression-free survival (C-index = 0.584, p = 0.036).
conclusionThe integrated multimodal model showed high accuracy and generalizability for preoperative LSCC staging and may aid individualized treatment planning. KEY POINTS: Question Can a multimodal deep learning model combining clinical, CT, and laryngoscopic data improve preoperative staging accuracy of LSCC? Findings The integrated multimodal model achieved higher diagnostic accuracy and provided reliable prognostic stratification compared with conventional approaches. Clinical relevance This multimodal model offers a non-invasive, accurate, and generalizable tool for LSCC staging, supporting individualized treatment planning and enhancing patient management.
Indexed as
Identifiers
41617832What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.